[en] Mucormycosis is an invasive fungal infection belonging to order of Mucorales which causes a high rate of mortality. This infection is mostly common in the immunosuppression conditions such as diabetes mellitus, chemotherapy, organ transplantation and hematologic malignancies.
Disciplines :
Otolaryngology
Author, co-author :
Khosravi, Mohammad Hossein ; Université de Liège - ULiège ; Department of Otorhinolaryngology Research Association (IORA), Universal Scientific Education and Research Network, Iran
Zahra, K; Student Research Committee, Semnan University of Medical Sciences, Semnan, Iran
Hosseini, M A; Student Research Committee, Qazvin University of Medical Sciences, Qazvin, Iran
Dadgar, S; Medical Student, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Ziya, D; Department of Plastic and Reconstructive Surgery, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
Saeedi, M; Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran
Serris A, Danion F, Lanternier F. Disease Entities in Mucormycosis. Journal of Fungi. 2019;5(1):23-4
Liu M, Spellberg B, Phan QT, Fu Y, Fu Y, Lee AS, et al. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. The Journal of clinical investigation. 2010;120(6):1914-24
Richardson M. The ecology of the Zygomycetes and its impact on environmental exposure. Clinical Microbiology and Infection. 2009;15:2-9
Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DC, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clinical Microbiology and Infection. 2018
Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. Journal of Fungi. 2019;5(1):26
Vaughan C, Bartolo A, Vallabh N, Leong SC. A metaanalysis of survival factors in rhinoorbitalcerebral mucormycosis has anything changed in the past 20 years Clinical Otolaryngology. 2018;43(6):1454-64
Wali U, Balkhair A, Al-Mujaini A. Cerebro-rhino orbital mucormycosis: An update. Journal of infection and public health. 2012;5(2):116-26
Therakathu J, Prabhu S, Irodi A, Sudhakar SV, Yadav VK, Rupa V. Imaging features of rhinocerebral mucormycosis: A study of 43 patients. The Egyptian Journal of Radiology and Nuclear Medicine. 2018;49(2):447-52
Corzo-León DE, Chora-Hernández LD, Rodríguez-Zulueta AP, Walsh TJ. Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases. Medical mycology. 2017;56(1):29-43
Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K, et al. Zygomycosis in Europe: Analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clinical Microbiology and Infection. 2011;17(12):1859-67.
